A research team led by Arun Sanyal, M.D., director of Virginia Commonwealth Universitys Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, and Philip Newsome, Ph.D., of Kings College London, has been involved in the clinical trials exploring the potential of semaglutide the GLP-1 receptor agonist used for Wegovy and Ozempic to treat people with this type of liver disease
Monitoring blood glucose levels closely, particularly during dose adjustments, helps ensure safety
So I'm going to cover those questions for you today
Vahl et al., 2007) and brain (Cork et al., 2015
Developed with pea protein, these chocolates add around 5g of protein per serving, opening up possibilities for brands looking to add functionality to indulgent bars, bites or inclusions
Reports have found that in extremely rare cases, pancreatitis, thyroid tumors, and gastroparesis may be connected to semaglutide